Oral Iloprost Improves Endobronchial Dysplasia in Former Smokers

There are no established chemopreventive agents for lung cancer, the leading cause of cancer death in the United States. Prostacyclin levels are low in lung cancer and supplementation prevents lung cancer in preclinical models. We carried out a multicenter double-blind, randomized, phase II placebo-...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Keith, Robert L., Blatchford, Patrick J., Kittelson, John, Minna, John D., Kelly, Karen, Massion, Pierre P., Franklin, Wilbur A., Mao, Jenny, Wilson, David O., Merrick, Daniel T., Hirsch, Fred R., Kennedy, Timothy C., Bunn, Paul A., Geraci, Mark W., Miller, York E.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251330/
https://ncbi.nlm.nih.gov/pubmed/21636546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0057
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items